Markets.com Logo

SV5

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    23.3735$
  • Previous Close
    23.3735$
  • 52 Week Change
    9.20$
  • Day Range
    0.00$
  • 52 Week High/Low
    16.8$ - 26$
  • Dividend Per Share
    --
  • Market cap
    415 M$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

SV5.BE is the stock ticker symbol for Ageas SA/NV on the Euronext Brussels stock exchange. Ageas is a multinational insurance company based in Belgium, offering life and non-life insurance products to individual and business customers. The .BE suffix indicates that the stock is traded on the Brussels exchange.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Company Performance: Positive earnings reports, revenue growth, and successful product launches typically drive the stock price up, while losses or setbacks can cause it to fall.

Industry Trends: The overall health and growth prospects of the biotechnology industry, as well as specific advancements in gene therapy, impact investor sentiment towards SV5.BE.

Market Conditions: General economic conditions, such as interest rates, inflation, and investor confidence, can influence the broader stock market and, consequently, SV5.BE.

Regulatory Landscape: Changes in government regulations related to drug approvals, pricing, and healthcare policy can significantly affect the profitability and valuation of biotechnology companies like SV5.BE.

Clinical Trial Results: Positive outcomes from clinical trials for SV5.BE's investigational therapies are crucial for attracting investment and boosting the stock price, while negative results can have the opposite effect.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--